A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

Insulin efsitora alfa (investigational once-weekly basal insulin): In another ADA-sponsored symposium, Lilly will share results from the QWINT-1, QWINT-3 and QWINT-4 Phase 3 trials, which evaluated ...

On Wednesday night, the couple’s 27-year-old daughter, Savannah, shared the first footage of her dad following his release ...

Tom Nolan reviews this week’s research Giving a hearing aid to people with untreated hearing loss helps them retain one additional person in their social network over a three year period. This catchy ...

Detailed price information for Vivani Medical Inc (VANI-Q) from The Globe and Mail including charting and trades.

Veru reports strong safety and efficacy for enobosarm added to semaglutide, showing reduced functional decline and muscle ...

76-year-old John Kane from Killiney, Dublin, remarked at his own experience with a drug similar to Ozempic and highlighted ...

View online. YOUR MORNINGMay 27, 2025 Good morning, NewsNation. For more fact-based, unbiased news coverage 24/7 – Download ...

Background: Canada has historically been among the world leaders in hypertension care, but hypertension treatment and control ...

The prospect of reducing the risk of some very common cancers adds the weight of evidence behind the GLP-1 agonist class, ...

India's healthtech space is expected to witness disruption as weight loss drugs Ozempic and Mounjaro enter the market through ...

Despite low obesity rates, Korea sees high demand for Wegovy, prompting misuse and regulatory concerns amid societal ...